GAITHERSBURG, Md. (AP) _ Emergent Biosolutions Inc. (EBS) on Thursday reported fourth-quarter profit of $185.4 million.
The Gaithersburg, Maryland-based company said it had profit of $3.44 per share. Earnings, adjusted for one-time gains and costs, came to $3.67 per share.
The biopharmaceutical company posted revenue of $583 million in the period.
For the year, the company reported profit of $305.1 million, or $5.67 per share. Revenue was reported as $1.56 billion.
Emergent Biosolutions shares have risen 31% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $117.06, a rise of 84% in the last 12 months.